- Home
- ACTU vs MPA Comparison
ACTU vs MPA Comparison
Compare ACTU & MPA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ACTU
- MPA
- Stock Information
- Founded
- ACTU 2015
- MPA 1992
- Country
- ACTU United States
- MPA United States
- Employees
- ACTU N/A
- MPA N/A
- Industry
- ACTU
- MPA Finance Companies
- Sector
- ACTU
- MPA Finance
- Exchange
- ACTU NYSE
- MPA Nasdaq
- Market Cap
- ACTU 153.1M
- MPA 159.3M
- IPO Year
- ACTU 2024
- MPA N/A
- Fundamental
- Price
- ACTU $7.53
- MPA $11.46
- Analyst Decision
- ACTU
- MPA
- Analyst Count
- ACTU 0
- MPA 0
- Target Price
- ACTU N/A
- MPA N/A
- AVG Volume (30 Days)
- ACTU 74.0K
- MPA 25.2K
- Earning Date
- ACTU 11-13-2024
- MPA 01-01-0001
- Dividend Yield
- ACTU N/A
- MPA 3.83%
- EPS Growth
- ACTU N/A
- MPA N/A
- EPS
- ACTU N/A
- MPA N/A
- Revenue
- ACTU N/A
- MPA N/A
- Revenue This Year
- ACTU N/A
- MPA N/A
- Revenue Next Year
- ACTU N/A
- MPA N/A
- P/E Ratio
- ACTU N/A
- MPA N/A
- Revenue Growth
- ACTU N/A
- MPA N/A
- 52 Week Low
- ACTU $5.51
- MPA $9.87
- 52 Week High
- ACTU $10.16
- MPA $12.21
- Technical
- Relative Strength Index (RSI)
- ACTU N/A
- MPA 26.11
- Support Level
- ACTU N/A
- MPA $11.36
- Resistance Level
- ACTU N/A
- MPA $12.55
- Average True Range (ATR)
- ACTU 0.00
- MPA 0.17
- MACD
- ACTU 0.00
- MPA -0.10
- Stochastic Oscillator
- ACTU 0.00
- MPA 8.40
About ACTU ACTUATE THERAPEUTICS INC
Actuate Therapeutics Inc is a clinical stage biopharmaceutical company focused on developing therapies for the treatment of high impact, difficult to treat cancers through the inhibition of glycogen synthase kinase-3 (GSK-3). It is developing elraglusib (formerly 9-ING-41), a small molecule that is designed to enter cancer cells and block the function of the enzyme GSK-3β, a master regulator of complex biological signaling cascades, including those mediated by oncogenes, that lead to tumor cell survival, growth, migration, and invasion.
About MPA Blackrock MuniYield Pennsylvania Quality Fund
Blackrock Muniyield Pennsylvania Quality Fund is a closed-end fund with investment objective is to provide shareholders with current income exempt from U.S. federal and Pennsylvania income taxes.